Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

Rhea-AI Summary

Harrow (Nasdaq: HROW) will report third quarter 2025 financial results for the period ended September 30, 2025, on Monday, November 10, 2025 after market close. The company said it will post a Third Quarter Letter to Stockholders on its Investors page at harrow.com.

Harrow will host a conference call and live webcast at 8:00 a.m. ET on Tuesday, November 11, 2025 to discuss results and provide a business update. A replay will be available on the company website for one year. Telephone participants must register in advance to receive a unique dial-in and PIN.

Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025

NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the third quarter ended September 30, 2025, on Monday, November 10, 2025, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, November 11, 2025, to discuss the results and provide a business update.

Conference Call Information
Participants can access the live webcast of Harrow’s presentation on the “Investors” page of Harrow’s website. A replay of the webcast will be available on the Company’s website for one year.

To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call.

About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com.

Contact:
Mike Biega
VP of Investor Relations & Communications
mbiega@harrowinc.com
617-913-8890

FAQ

When will Harrow (HROW) report Q3 2025 results?

Harrow will report third quarter 2025 results after market close on Monday, November 10, 2025.

What time is the Harrow (HROW) conference call to discuss Q3 2025 results?

The conference call and live webcast are scheduled for 8:00 a.m. Eastern Time on November 11, 2025.

Where can I find Harrow's (HROW) Third Quarter Letter to Stockholders for 2025?

The letter will be posted on Harrow's Investors page at harrow.com after the results are released.

How long will the Harrow (HROW) webcast replay be available?

A replay of the webcast will be available on Harrow's website for one year.

How do I join Harrow's (HROW) Q3 2025 conference call by phone?

Register in advance via the provided registration link; registrants receive a confirmation email with a unique dial-in number and PIN.

What will Harrow (HROW) cover on the Q3 2025 earnings call?

Harrow will discuss its third quarter 2025 financial results and provide a company business update during the call.